Market Context — Why This Technology, Why Now

Consumers worldwide are increasingly seeking functional foods that offer specific health benefits, driving significant growth in the plant-based and gut health sectors. Regulatory bodies are also encouraging healthier food options, while competitive dynamics demand differentiated products. This technology enables manufacturers to meet these demands by delivering superior taste and verified digestive comfort, positioning them to capture a larger share of the estimated multi-billion dollar global market for functional plant-based products.

Key Competitive Advantages
01

Enables specific functional ingredient generation by assimilating only oligosaccharides, not sucrose, offering clear product differentiation.

02

Reduces off-flavors in soy milk, achieving a pleasant taste and yogurt-like texture, potentially establishing a competitive edge in plant-based yogurt.

03

Prevents flatulence associated with oligosaccharide intake, enhancing consumer digestive comfort and appealing to health-conscious demographics.

Market Opportunity
🌱 Plant-Based Dairy Alternatives
$1.5B–$2B globally (AI est.)
Rising health consciousness and environmental awareness are driving demand for plant-based dairy alternatives like soy yogurt. This technology's superior flavor profile enhances market competitiveness.
Plant-based food manufacturers Dairy alternative producers Fermented food innovators
🍎 Functional Foods & Gut Health
$30B–$35B globally (AI est.)
Growing interest in gut microbiome improvement sustains demand for probiotic and prebiotic-containing foods. The flatulence prevention effect provides clear added value.
Probiotic supplement manufacturers Functional beverage companies Health food ingredient suppliers
💊 Foods for Specified Health Uses (FOSHU)
$1.5B–$2B globally (AI est.)
Expected clear benefits for the digestive system allow for development as Foods with Function Claims or FOSHU products, enabling monetization in high-price segments.
Pharmaceutical food divisions Medical nutrition companies Premium health product brands
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent represents a stable right, having been granted after a standard prior art search, indicating high recognition for its uniqueness and inventiveness. It features 10 claims, comprehensively protecting the strain itself and its various application methods, providing a robust and exclusive right for business operations.

Competitive White Space

This patent primarily covers a specific lactic acid bacteria strain and its use in oligosaccharide fermentation. Adjacent white space includes developing novel fermentation processes with different microbial strains, exploring non-food applications for this strain, or integrating it into complex microbial consortia for broader functional outcomes.

Economic Impact
~$1M/year estimated new market creation potential (AI est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

This technology could open up 5% of the high-value segment within the domestic plant-based yogurt market (estimated at ~$135M (AI est.), growing at 8%), equating to ~$6.5M (AI est.) in new market opportunity. Exclusive utilization of this technology could capture 15% of this new market, generating ~$1M (AI est.) annually. This market is projected to expand further, offering a long-term revenue stream.

Speed to Market
5× faster than in-house development
This technology focuses on a specific lactic acid bacteria strain (Leugolactobacillus coliniformis AL3G1, accession number NITE BP-04155) with clearly defined characteristics. This allows adopting companies to significantly bypass initial strain discovery and basic research phases, focusing directly on safety and efficacy evaluations. As a research outcome from a national R&D agency, it provides a reliable foundational technology for rapid application development in food processing.
Competitive Positioning

X: Product Differentiation Advantage
Y: Health Functionality Contribution

Business Models & Applications
🧪 Lactic Acid Bacteria Starter Supply
Supply this strain as a fermentation starter to food manufacturers. This model generates royalty income by contributing to quality improvement in specific oligosaccharide-containing foods (e.g., soy milk, legume products).
🤝 Functional Food Co-Development
Collaborate with food manufacturers to co-develop new functional soy yogurts, fermented beverages, or supplements using this strain. Revenue sharing from technology provision and product sales is anticipated.
📄 Technology Licensing
Grant licenses to implement this patent, enabling companies to develop, manufacture, and sell their own products. This fosters expansion into diverse industries and secures stable licensing revenue.
Adjacent Application Opportunities
👶 Infant & Toddler Foods
Digestive-Friendly Baby & Toddler Meals
Apply this functional lactic acid bacteria to soy-based baby food or toddler yogurts, aiding oligosaccharide digestion and preventing flatulence in infants' underdeveloped digestive systems. This could create value as an allergy-friendly food option, potentially reducing digestive discomfort by up to 30%.
💊 Medical & Care Foods
Digestive Support for Seniors
Develop care foods or medical foods for seniors that efficiently assimilate oligosaccharides and reduce flatulence, addressing age-related digestive decline and gut health issues. This could contribute to improved nutrient absorption by 10-15% and enhanced quality of life for elderly patients.
🌿 Vegan & Alternative Proteins
Plant-Based Cheese & Fermented Condiments
Beyond soy yogurt, this technology could be applied to plant-based cheeses and fermented condiments, improving flavor and adding functionality. This could contribute to the diversification and premiumization of plant-based foods, enhancing flavor profiles and texture by 20-25%.
Integration Roadmap — Estimated 17-Month Deployment
Phase 1: Technology Evaluation & PoC
Duration: 4 months
Evaluate the detailed characteristics of this strain and conduct small-scale trials with the licensee's existing facilities. Confirm fermentation suitability with oligosaccharide-containing raw materials other than soy milk, and refine product concepts.
Phase 2: Product Development & Process Optimization
Duration: 9 months
Develop specific product recipes (e.g., soy yogurt) and optimize manufacturing processes using the selected raw materials and strain. Repeatedly evaluate flavor, texture, and storage stability.
Phase 3: Market Launch & Mass Production
Duration: 4 months
Establish a mass production system based on the optimized process. After addressing regulatory compliance, establishing quality control, and formulating marketing strategies, introduce the product to the market and commence full-scale business operations.
Technical Feasibility
The core of this technology, the Leugolactobacillus coliniformis AL3G1 strain (accession number NITE BP-04155), is clearly identified and deposited by a national R&D agency, ensuring stable supply and quality. This eliminates the need for de novo strain development, allowing for relatively easy integration into existing fermentation equipment and production lines through optimization of culture conditions and product formulation.
Success Scenario
Upon adopting this technology, a licensee could resolve existing flavor challenges in conventional soy-fermented products, enabling the development of differentiated, 'great-tasting plant-based yogurts'. This could lead to acquiring new customer segments and enhancing brand value. Furthermore, by promoting the flatulence prevention effect associated with oligosaccharide intake, the licensee could gain support from health-conscious consumers, estimated to increase annual sales by 10-15% compared to current levels.
Patent Record
APPLICATION NO.
JP2025-572164
REGISTRATION NO.
7837116
FILING DATE
2025/12/02
GRANT DATE
2026/03/19
EXPIRATION DATE
2045/12/02
PATENT HOLDER
国立研究開発法人農業・食品産業技術総合研究機構
Examination History
2025-12-10
Statement Requesting Accelerated Examination
2025-12-10
Request for Examination
2026-01-20
Notice re: Accelerated Examination
2026-02-17
Decision to Grant